KCAP Financial, Inc. Announces Full Year 2017 Financial Results
Mar 07, 2018 21:07 pm UTC| Business
NEW YORK, March 07, 2018 -- KCAP Financial, Inc. (Nasdaq:KCAP) (“KCAP” or the “Company”) announces its full year 2017 financial results.Financial Highlights Net investment income for the year ended December 31, 2017...
ZAGG Reports Record 2017 Fourth Quarter and Full Year Results
Mar 07, 2018 21:07 pm UTC| Business
SALT LAKE CITY, March 07, 2018 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, today announced financial results for the fourth quarter and twelve months ended December 31, 2017. Fourth Quarter...
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
Mar 07, 2018 21:06 pm UTC| Business
BURLINGAME, Calif., March 07, 2018 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and antibody agents that...
AIT Therapeutics to Present at Two Investor Conferences
Mar 07, 2018 21:06 pm UTC| Business
REHOVOT, Israel and NEW YORK, March 07, 2018 -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious...
Mar 07, 2018 21:06 pm UTC| Business
GAITHERSBURG, Md., March 07, 2018 -- Novavax, Inc. (Nasdaq:NVAX) today announced it will provide a corporate update and report its fourth quarter and full year 2017 financial and operating results following the close of...
MYR Group Inc. Announces Fourth-Quarter and Full-Year 2017 Results
Mar 07, 2018 21:06 pm UTC| Business
ROLLING MEADOWS, Ill., March 07, 2018 -- MYR Group Inc. (“MYR” or the “Company”) (NASDAQ:MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial...
Checkpoint Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Mar 07, 2018 21:06 pm UTC| Business
NEW YORK, March 07, 2018 -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (Nasdaq:CKPT), a Fortress Biotech (Nasdaq:FBIO) company, today announced that it is proposing to offer and sell, subject to...